°øÀ¯Çϱâ
ºñ±³ÇÏ¸é º¸ÀÌ´Â ¾à vs. ¾à 1
±¸¸ÅÈıâ 0°³ (0)
¤ýµµ¼­Á¤º¸ ÀúÀÚ : Çѱ¹¾à»ç±³À°¿¬±¸È¸
ÃâÆÇ»ç : ¾à»ç°ø·Ð
2022³â 02¿ù 17ÀÏ Ãâ°£  |  ISBN : 1192269012  |  544ÂÊ
¤ý±³º¸È¸¿ø ±³º¸¹®°í ID ¿¬°áÇϱâ
µµ¼­¸¦ ±¸ÀÔÇÏ½Ã¸é ±³º¸¹®°í¿Í ²É¸¶ÀÇ È¸¿øÇýÅÃÀ» ÇÔ²²
¹ÞÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù.
¤ý²É¸¶°¡ 45,000¿ø 40,500¿ø 10%
¤ýÃß°¡ÇýÅà ²É 3¼ÛÀÌ
²É¼ÛÀÌÁö°© ¸¸µé±â>
²É¼ÛÀÌ Àû¸³À» À§Çؼ­ '²É¼ÛÀÌÁö°©'À» ¸¸µå¼Å¾ß ÇÕ´Ï´Ù.
¤ý¹è¼ÛÁö¿ª ±¹³»
¤ý¹è¼Ûºñ
Á¶°ÇºÎ¹«·á¹è¼Û
  • ÀÌ °¡°ÔÀÇ ¹«·á¹è¼Û »óǰÀ» ÇÔ²² ÁÖ¹®Çϰųª, ÃÑÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÌ¸é ¹«·á¹è¼Û.
  • 15,000¿ø ¹Ì¸¸ÀÌ¸é ¹è¼Ûºñ 2,500¿ø °í°´ºÎ´ã
  • µµ¼­»ê°£/Á¦ÁÖµµ´Â Ãß°¡¿îÀÓºñ ºÎ°úµÉ ¼ö ÀÖÀ½
2ÀÏ À̳» Ãâ°í
¤ý¼ö·®
ÃÑ ÇÕ°è±Ý¾×  ¿ø
Âò
¼±¹°
Àå¹Ù±¸´Ï ´ã±â
¹Ù·Î ±¸¸ÅÇϱâ

Àå¹Ù±¸´Ï¿¡ ´ã¾Ò½À´Ï´Ù. Àå¹Ù±¸´Ï¸¦ È®ÀÎ ÇϽðڽÀ´Ï±î?

¼îÇΰè¼ÓÇϱâ
Àå¹Ù±¸´Ïº¸±â
¤ýÀÌ °¡°ÔÀÇ ´Ù¸¥ »óǰ ¸ðµç»óǰº¸±â+
22,000¿ø
19,800¿ø 10%¡é
18,000¿ø
16,200¿ø 10%¡é
21,900¿ø
19,710¿ø 10%¡é
12,000¿ø
10,800¿ø 10%¡é
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
²ÞÀ» ÇÇ¿ì´Â ¼¼»ó, ÀÎÅÍ³Ý ±³º¸¹®°íÀÔ´Ï´Ù.
°¡°ÔÁÖÀÎ : ±³º¸¹®°í
ÀüÈ­ ¹× ÅùèÁ¤º¸
ÀüÈ­ ¹× ÅùèÁ¤º¸
»óǰ ¾È³» ¹× ȯºÒ, ±³È¯, ¹è¼Û¹®ÀÇ
- °¡°Ô ÀüÈ­¹øÈ£ : 1544-1900
- ÀüÈ­¹®ÀÇ ½Ã°£ : ¿ÀÀü 9½ÃºÎÅÍ ¿ÀÈÄ 6½Ã±îÁö
(¸ÅÁÖ ¿ù¿äÀÏ, È­¿äÀÏ, ¼ö¿äÀÏ, ¸ñ¿äÀÏ, ±Ý¿äÀÏ, °øÈÞÀÏ Á¦¿Ü)
- °¡°Ô À̸ÞÀÏ : ink@kyobobook.co.kr
- ÀÌ¿ë Åùèȸ»ç : CJ´ëÇÑÅë¿î
ÆÇ¸Å°¡°ÔÁ¤º¸
- »ç¾÷ÀÚ¸í : (ÁÖ)±³º¸¹®°í
- »ç¾÷ÀÚµî·Ï¹øÈ£ : 102-81-11670
- Åë½ÅÆÇ¸Å¾÷½Å°í : 01-0653
- Çö±Ý¿µ¼öÁõ : ¹ß±Þ°¡´É
ÀüÈ­ÁÖ¹® ¹× °áÁ¦¹®ÀÇ
- ²ÉÇÇ´Â ¾ÆÄ§¸¶À» : 1644-8422
°¡°Ô¿Í Á÷°Å·¡¸¦ ÇÏ½Ã¸é ²É¼ÛÀÌ Àû¸³ ¹× °¢Á¾ ÇýÅÿ¡¼­
Á¦¿ÜµÇ°í, ¸¸ÀÏÀÇ ¹®Á¦°¡ ¹ß»ýÇÏ´Â °æ¿ì¿¡µµ ²É¸¶ÀÇ
µµ¿òÀ» ¹ÞÀ¸½Ç ¼ö ¾ø½À´Ï´Ù. °¡°ÔÀÇ ºÎ´çÇÑ ¿ä±¸,
ºÒ°øÁ¤ ÇàÀ§ µî¿¡ ´ëÇØ¼­µµ ²É¸¶·Î Á÷Á¢ ÀüÈ­ÁÖ¼¼¿ä.
 À̾߱â²É¹ç
µî·ÏµÈ À̾߱Ⱑ ¾ø½À´Ï´Ù.
»ó¼¼Á¤º¸ ±¸¸ÅÈıâ (0°³)
(0)
»óǰ Q&A (0) ¹è¼Û/±³È¯/ȯºÒ ¾È³»

Ã¥¼Ò°³

¾à¹° ºñ±³¸¦ ÇÑ´«¿¡! ¾à»ç¿Í ȯÀÚ¸¦ À§ÇÑ ½Ç¿ë¡¤¸ÂÃã ÀǾà Á¤º¸¼­ ´ëÇѾà»çȸ ¾à»ç°ø·Ð, 7³â°£ÀÇ ³ëÇϿ츦 Áý¾àÇÑ ½Ç¹« °¡À̵åºÏ ¼±º¸¿© ´ëÇѾà»çȸ ¾à»ç°ø·Ð(»çÀå ±èÁ¾È¯)°ú Çѱ¹¾à»ç±³À°¿¬±¸È¸(ȸÀå Á¤°æÇý)´Â ¾à»ç°ø·ÐÀÇ ´ëÇ¥ ¿¬Àç ÄÚ³ÊÀÎ ¡´¾à vs å· ²Ä²Ä ºñ±³¡µ¸¦ ´ÜÇົÀ¸·Î ¿«Àº ¡¸ºñ±³ÇÏ¸é º¸ÀÌ´Â ¾à vs ¾à¡¹ Á¦1±ÇÀ» ±³º¸¹®°í¸¦ ÅëÇØ ¼±º¸Àδٰí ÀüÇß´Ù. À̹ø Ãâ°£Àº 2015³â ¾à»ç°ø·Ð¿¡¼­ ù ¿¬À縦 ½ÃÀÛÇÑ ÀÌ·¡ 7³â µ¿¾È ÃàÀûµÈ Àü¹® Áö½Ä°ú ÇöÀå °æÇè, ±×¸®°í µ¶ÀÚµéÀÇ ²ÙÁØÇÑ ¿äûÀÌ °á½ÇÀ» ¸ÎÀº ÀÇ¹Ì ÀÖ´Â ¼º°ú´Ù. ¿¬Àç ±â°£ µ¿¾È ¾à»çµé°ú ÀÇ·áÁøµé·ÎºÎÅÍ "½Ç¹«¿¡ ¹Ù·Î Àû¿ëÇÒ ¼ö ÀÖ´Â À¯¿ëÇÑ Á¤º¸"¶ó´Â È£ÆòÀ» ¹Þ¾Æ¿ÔÀ¸¸ç, À̸¦ ü°èÀûÀ¸·Î Á¤¸®ÇÑ ´ÜÇົ¿¡ ´ëÇÑ ±â´ë°¡ ³ô¾ÆÁö°í ÀÖ´Ù. ½ÉÇ÷°ü¡¤È£Èí±â¡¤³»ºÐºñ Áúȯ, ¾à±¹ ÇöÀå ÇÙ½É ºÐ¾ß ÁýÁß ±¸¼º Á¦1±ÇÀº ¾à±¹ ÇöÀå¿¡¼­ °¡Àå ºó¹øÇÏ°Ô Á¢ÇÏ°Ô µÇ´Â ½ÉÇ÷°üÁúȯ, È£Èí±âÁúȯ, ³»ºÐºñÁúȯ, ¿©¼ºÁúȯ, ¼ÒÈ­±âÁúȯ, °£Áúȯ, ½ÅÀåÁúȯ, ºñ´¢»ý½Ä±âÁúȯ µî 8°³ ºÐ¾ß¸¦ Áß½ÉÀ¸·Î ±¸¼ºµÇ¾ú´Ù. À̵é ÁúȯÀº ±¹¹Î °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ Å©°í, ´Ù¾çÇÑ Ä¡·á ¿É¼ÇÀÌ Á¸ÀçÇØ ¾à»çµéÀÇ Àü¹®ÀûÀÎ ÆÇ´ÜÀÌ Æ¯È÷ Áß¿äÇÑ ¿µ¿ªÀÌ´Ù. Ã¥ÀÇ °¡Àå Å« Ư¡Àº °°Àº Áúȯ Ä¡·á¿¡ »ç¿ëµÇÁö¸¸ ¾à¸®±âÀü, ÀûÀÀÁõ, ºÎÀÛ¿ëÀÌ ¼­·Î ´Ù¸¥ ¾à¹°µéÀ» Á÷Á¢ ºñ±³ÇÏ¿© Á¦½ÃÇÑ´Ù´Â Á¡ÀÌ´Ù. À̸¦ ÅëÇØ ¾à»çµéÀÌ È¯ÀÚÀÇ °³º° »óȲ¿¡ µû¶ó ÃÖÀûÀÇ ¾à¹°À» ¼±ÅÃÇϰí, ÀûÀýÇÑ º¹¾àÁöµµ¸¦ ÇÒ ¼ö ÀÖµµ·Ï µ½´Â´Ù. Q&A ¹æ½ÄÀ¸·Î ½±°í ¸íÈ®ÇÑ ÀÌÇØ µµ¸ð º¹ÀâÇÑ ÀǾà Á¤º¸¸¦ º¸´Ù ½±°Ô Àü´ÞÇϱâ À§ÇØ ¹®´ä(Q&A) Çü½ÄÀ» äÅÃÇß´Ù. ½ÇÁ¦ ¾à±¹ ÇöÀå¿¡¼­ ÀÚÁÖ Á¦±âµÇ´Â Áú¹®µéÀ» ¹ÙÅÁÀ¸·Î ±¸¼ºµÈ ÀÌ ¹æ½ÄÀº µ¶ÀÚµéÀÌ ±Ã±ÝÇØÇÒ ¸¸ÇÑ ³»¿ëÀ» ¸ÕÀú Á¦½ÃÇϰí, ÀÌ¿¡ ´ëÇÑ ÇÙ½ÉÀûÀÌ°í ½Ç¿ëÀûÀÎ ´äº¯À» ¸íÈ®ÇÏ°Ô Á¦°øÇÑ´Ù. ¶ÇÇÑ °¢ ¾à¹° ºñ±³ ¼½¼Ç¸¶´Ù 'À̰͸¸Àº ¾Ë¾ÆµÎ¼¼¿ä' Äڳʸ¦ º°µµ·Î ¸¶·ÃÇÏ¿©, ¾à¹° ¼±Åðú º¹¿ë Áöµµ ½Ã ¹Ýµå½Ã ¼÷ÁöÇØ¾ß ÇÒ ÇÙ½É Æ÷ÀÎÆ®µéÀ» ÇÑ´«¿¡ Á¤¸®Çß´Ù. ÀÌ´Â ¹Ù»Û ¾à±¹ ¾÷¹« Áß¿¡µµ ºü¸£°Ô ÂüÁ¶ÇÒ ¼ö ÀÖ¾î ½Ç¹« Ȱ¿ëµµ¸¦ Å©°Ô ³ôÀÎ ±¸¼ºÀÌ´Ù. "±Ù°Å Á᫐ ½Ç¹« Áöħ¼­·Î ÀÚ¸®¸Å±è ±â´ë" Á¤°æÇý Çѱ¹¾à»ç±³À°¿¬±¸È¸ ȸÀåÀº "ÇöÀç ÀǾà ȯ°æÀº »õ·Î¿î Á¦µµ µµÀÔ, Çõ½Å ½Å¾àÀÇ Áö¼ÓÀû µîÀå, ¸ÂÃãÇü ¾à·á ¼­ºñ½º È®´ë µîÀ¸·Î ÀÎÇØ ¸Å¿ì ºü¸£°Ô º¯È­Çϰí ÀÖ´Ù"¸ç Ãâ°£ ¹è°æÀ» ¼³¸íÇß´Ù. À̾î "ÀÌ·¯ÇÑ º¯È­ ¼Ó¿¡¼­ ÇöÀåÀÇ ¾à»çµéÀÌ º¸´Ù Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ȯÀÚ¸¦ ¸¸³¯ ¼ö ÀÖµµ·Ï µ½°íÀÚ Çß´Ù"¸ç, "À̹ø Ã¥ÀÌ ÇöÀå¿¡¼­ ȯÀÚ¸¦ Á÷Á¢ ¸¸³ª´Â ¸ðµç ¾à»çµé¿¡°Ô ±Ù°Å Áß½ÉÀÇ ½Ç¹« Áöħ¼­·Î ÀÚ¸®Àâ±â¸¦ ¹Ù¶õ´Ù"°í Ãâ°£ ÀÇÀǸ¦ ¹àÇû´Ù. ÇÑÆí, ¾à»ç°ø·Ð ÃøÀº "Á¦1±Ç°ú ÇÔ²² Á¦2±Çµµ µ¿½Ã¿¡ Ãâ°£µÇ¾úÀ¸¸ç, µÎ ±ÇÀÌ ¼¼Æ®·Î ±¸¼ºµÇ¾î ÀÖ´Ù"¸ç, "º¸´Ù ¿Ï¼ºµµ ³ôÀº ¾à¹° ºñ±³ Á¤º¸¸¦ ¿øÇÏ´Â µ¶ÀÚµéÀº Á¦2±Çµµ ÇÔ²² ÂüÁ¶ÇØ ÁÖ½Ã±æ ¹Ù¶õ´Ù"°í ÀüÇß´Ù.

¸ñÂ÷

ÀÌ Ã¥À» ³»¸é¼­?4 1 ½ÉÇ÷°ü Áúȯ 13 °íÇ÷¾Ð?Hypertension?15 Çù½ÉÁõ?Angina Pectoris?19 ¾Ï·ÎµðÇÉ(Amlodipine) vs. ·Î»ç¸£Åº(Losartan)?23 ¾Ï·ÎµðÇÉ(Amlodipine) vs. µôƼ¾ÆÁª(Diltiazem)?27 È÷µå·ÎŬ·Î·ÎƼ¾ÆÁöµå(Hydrochlorothiazide) vs. ½ºÇǷγë¶ôÅæ(Spironolactone)?31 ÇÁ·ÎÇÁ¶ó³î·Ñ(Propranolol) vs. Ä«¸£º£µô·Ñ(Carvedilol)?35 Ä«¸£º£µô·Ñ(Carvedilol) vs. ³×ºñº¸·Ñ(Nebivolol)?39 ´ÏÆäµðÇÉ(Nifedipine) vs. º£¶óÆÄ¹Ð(Verapamil)?42 Æ®·¹ÇÁ·Î½ºÆ¼´Ò(Treprostinil) vs. ¼¿·¹½ÃÆÅ(Selexipag)?45 ´ÏÆ®·Î±Û¸®¼¼¸°(Nitroglycerin) vs. À̼ҼҸ£ºñµåÀÌÁú»ê¿°(Isosorbide dinitrate)?49 ´ÏÄÚ¶õµô(Nicorandil) vs. ¸ô½Ãµµ¹Î(Molsidomine)?53 ½ÉºÎÀü?Heart Failure?57 ¶ó¹ÌÇÁ¸±(Ramipril) vs. ³×ºñº¸·Ñ(Nebivolol)?61 »çÄíºñÆ®¸±¡¤¹ß»ç¸£Åº(Sacubitril¡¤Valsartan) vs. ¿¡³¯¶óÇÁ¸±(Enalapril)?66 ºñ¼ÒÇÁ·Ñ·Ñ(Bisoprolol) vs. À̹ٺê¶óµò(Ivabradine)?70 ºÎÁ¤¸Æ?Arrhythmia?73 ¾Æ¹Ì¿À´Ù·Ð(Amiodarone) vs. ÇÁ·ÎÆÄÆä³í(Propafenone)?76 ¾Æ¹Ì¿À´Ù·Ð(Amiodarone) vs. µå·Î³×´Ù·Ð(Dronedarone)?79 ÀÌ»óÁöÁúÇ÷Áõ?Dyslipidemia?85 ÇÁ¶ó¹Ù½ºÅ¸Æ¾(Pravastatin) vs. ¾ÆÅ丣¹Ù½ºÅ¸Æ¾(Atorvastatin)?87 ·Î¼ö¹Ù½ºÅ¸Æ¾(Rosuvastatin) vs. ¿¡Á¦Æ¼¹Ìºê(Ezetimibe)?92 ¾Ë¸®·ÎÄí¸¿(Alirocumab) vs. ¿¡º¼·ÎÄí¸¿(Evolocumab)?97 Æä³ëÇǺ극ÀÌÆ®(Fenofibrate) vs. ¿À¸Þ°¡-3-»ê ¿¡Æ¿¿¡½ºÅ׸£90(Omega-3-acid ethyl esters)?101 Ç×Ç÷ÀüÁ¦?Antithrombic Agents?107 Ŭ·ÎÇǵµ±×·¼(Clopidogrel) vs. ÇÁ¶ó¼ö±×·¼(Prasugrel)?110 Ƽī±×·¼·¯(Ticagrelor) vs. Ŭ·ÎÇǵµ±×·¼(Clopidogrel)?114 ½Ç·Î½ºÅ¸Á¹(Cilostazol) vs. Ŭ·ÎÇǵµ±×·¼(Clopidogrel)?118 ÇìÆÄ¸°(Heparin) vs. ¿¡³ì»çÆÄ¸°(Enoxaparin)?121 ¿ÍÆÄ¸°(Warfarin) vs. ¸®¹Ù·Ï»ç¹Ý(Rivaroxaban)?125 ¾ÆÇÈ»ç¹Ý(Apixaban) vs. ´Ùºñ°¡Æ®¶õ(Dabigatran)?129 ¾Æ½ºÇǸ°(Aspirin) vs. ¿ÍÆÄ¸°(Warfarin)?134 ¾Æ½ºÇǸ°(Aspirin) vs. ¿¡µ¶»ç¹Ý(Edoxaban)?139 2 È£Èí±â Áúȯ 153 õ½Ä?Asthma?155 ¸¸¼º Æó¼â¼º ÆóÁúȯ?Chronic Obstructive Pulmonary Disease, COPD?158 ±âħ?Cough?161 ½ÉºñÄÚÆ®(Budesonide/Formoterol) vs. ÇÃ·çÆ¼Æû(Fluticasone/Formoterol)?163 Åø·ÎºÎÅ×·Ñ(Tulobuterol) vs. »ìºÎŸ¸ô(Salbutamol sulfate)?167 Ƽ¿ÀÆ®·ÎǾ(Tiotropium) vs. ÀδÙÄ«Å×·Ñ(Indacaterol)?172 µ¦»ç¸ÞŸ¼Õ(Dexamethasone) vs. ÇÁ·¹µå´Ï¼Ö·Ð(Prednisolone)?175 ÄÚµ¥ÀÎ(Codeine) vs. µðÈ÷µå·ÎÄÚµ¥ÀÎ(Dihydrocodeine)?180 µðÈ÷µå·ÎÄÚµ¥ÀÎ(Dihydrocodeine) vs. ·¹º¸µå·ÎÇÁ·ÎÇÇÁø(Levodropropizine)?184 ¾Ë·¹¸£±âºñ¿°?Allergic Rhinitis?189 Æå¼ÒÆä³ªµò(Fexofenadine) vs. ¿Ã·ÎÆÄŸµò(Olopatadine)?192 ¾ÆÁ©¶ó½ºÆ¾(Azelastine) vs. ¸ð¸ÞŸ¼Õ(Mometasone)?196 ¸ð¸ÞŸ¼Õ(Mometasone) vs. Æ®¸®¾Ï½Ã³î·Ð ¾Æ¼¼Åä´Ïµå(Triamcinolone acetonide)?200 ¼¼Æ¼¸®Áø(Cetirizine) vs. ·Î¶óŸµò(Loratadine)?204 3 ³»ºÐºñ Áúȯ 211 ´ç´¢º´?Diabetes Mellitus?213 ±Û¸®¸ÞÇǸ®µå(Glimepiride) vs. ¸ÞÆ®Æ÷¸£¹Î(Metformin)?216 ±Û¸®Å¬¶óÁöµå(Gliclazide) vs. º¸±Û¸®º¸½º(Voglibose)?220 µÑ¶ó±Û·çŸÀ̵å(Dulaglutide) vs. Àν¶¸°±Û¶óÁø(Insulin glargine)?225 Àν¶¸°±Û¶óÁø(Insulin glargine) vs. Àν¶¸°µðÅ͸Ó(Insulin detemir)?230 ·Îº£±Û¸®Å¸Á¸(Lobeglitazone) vs. »è»ç±Û¸³Æ¾(Saxagliptin)?235 ½ÃŸ±Û¸³Æ¾(Sitagliptin) vs. ¿¡º¸±Û¸³Æ¾(Evogliptin)?239 ¸®³ª±Û¸³Æ¾(Linagliptin) vs. ¿¢¼¼³ªÅ¸À̵å(Exenatide)?243 ¾ÆÄ«º¸Áî(Acarbose) vs. ·¹ÆÄ±Û¸®´Ïµå(Repaglinide)?246 ¿¢¼¼³ªÅ¸À̵å(Exenatide) vs. ¸®¶ó±Û·çƼµå(Liraglutide)?250 ÇÇ¿À±Û¸®Å¸Á¸(Pioglitazone) vs. ¿¥ÆÄ±Û¸®Ç÷ÎÁø(Empagliflozin)?254 °©»ó»ù Áúȯ?Thyroid Disease?259 ÄÞÁö·ÎÀ̵å(Comthyroid) vs. ¾ÀÁö·ÎÀ̵å(Synthyroid)?261 ¸ÞƼ¸¶Á¹(Methimazole) vs. ÇÁ·ÎÇÊÆ¼¿À¿ì¶ó½Ç(Propylthiouracil)?264 ºñ¸¸?Obesity?267 ³¯Æ®·º¼Õ/ºÎÇÁ·ÎÇÇ¿Â(Naltrexone/Bupropion) vs. ¿À¸£¸®½ºÅ¸Æ®(Orlistat)?269 ÆæÅ͹Î(Phentermine) vs. ¸®¶ó±Û·çƼµå(Liraglutide)?273 ³¯Æ®·º¼Õ/ºÎÇÁ·ÎÇÇ¿Â(Naltrexone/Bupropion) vs. ÆæÅ͹Π/ ÅäÇǶó¸ÞÀÌÆ®(Phentermine/Topiramate)?277 ¸®¶ó±Û·çƼµå(Liraglutide) vs. ÆæÅ͹Π/ ÅäÇǶó¸ÞÀÌÆ®(Phentermine / Topiramate)?282 4 ¿©¼º Áúȯ 291 ÇÇÀÓ?Contraception?293 ¿¡Æ¼´Ò¿¡½ºÆ®¶óµð¿Ã / ·¹º¸³ë¸£°Ô½ºÆ®·¼(Ethinylestradiol / Levonorgestrel) vs. ¿¡Æ¼´Ò¿¡½ºÆ®¶óµð¿Ã / µå·Î½ºÇÇ·¹³í(Ethinylestradiol / Drospirenone)?295 ·¹º¸³ë¸£°Ô½ºÆ®·¼(Levonorgestrel) vs. ¿ï¸®ÇÁ¸®½ºÅ»(Ulipristal)?299 Àڱ󻸷Áõ?Endometriosis?305 µð¿¡³ë°Ô½ºÆ®(Dienogest) vs. °í¼¼·¼¸°(Goserelin)?306 ºÒÀÓ?Infertility?309 Ŭ·Î¹ÌÆæ(Clomiphene) vs. ¸Þ³ëÆ®·ÎÇÉ(Menotropin)?311 °»³â±â Áõ»ó?Menopausal Symptoms?315 ¿¡½ºÆ®¶óµð¿Ã(Estradiol valerate) vs. Ƽº¼·Ð(Tibolone)?317 5 ¼ÒÈ­±â Áúȯ 323 À§½Äµµ¿ª·ùº´?Gastroesophageal Reflux Disease, GERD?325 ¼ÒÈ­¼º±Ë¾ç?Peptic Ulcer Disease, PUD?327 ¶õ¼ÒÇÁ¶óÁ¹(Lansoprazole) vs. µ¦½º¶õ¼ÒÇÁ¶óÁ¹(Dexlansoprazole)?328 ¿¡¼Ò¸ÞÇÁ¶óÁ¹(Esomeprazole) vs. Å×°íÇÁ¶óÀÜ(Tegoprazan)?333 ÆÇÅäÇÁ¶óÁ¹(Pantoprazole) vs. ·¹¹ÙÇÁ¶óÀÜ(Revaprazan)?337 ¹Ì¼ÒÇÁ·Î½ºÅç(Misoprostol) vs. ·¹¹Ù¹ÌÇǵå(Rebamipide)?340 ¾Ë±ä»ê³ªÆ®·ý(Sodium alginate) vs. ¾Ë¸¶°ÔÀÌÆ®(Almagate)?343 ¼³»ç?Diarrhea?347 º¯ºñ?Constipation?348 °ú¹Î¼ºÀåÁõÈıº?Irritable Bowel Syndrome, IBS?350 ·ÎÆä¶ó¸¶À̵å(Loperamide) vs. µð¿ÁŸÇìµå¶ö½º¸ßŸÀÌÆ®(Dioctahedral smectite)?352 ¶ôÅø·Î¿À½º(Lactulose) vs. »êÈ­¸¶±×³×½·(Magnesium oxide)?355 ºñ»çÄÚµô(Bisacodyl) vs. ÇÁ·çÄ®·ÎÇÁ¶óÀ̵å(Prucalopride)?360 ºñ»çÄÚµô(Bisacodyl) vs. ÇÇÄÚȲ»ê³ªÆ®·ý(Sodium picosulfate)?364 Æú¸®¿¡Æ¿·»±Û¸®ÄÝ(Polyethylene glycol) vs. ÇÇÄÚȲ»ê³ªÆ®·ý(Sodium picosulfate)?367 Æú¸®Ä«¸£º¸ÇÊÄ®½·(Polycarbophil Calcium) vs. µµÅ¥¼¼ÀÌÆ®(Docusate Sodium)?371 ¸®ÆÅ½Ã¹Î(Rifaximin) vs. ¶ó¸ð¼¼Æ®·Ð(Ramosetron)?376 Æ®¸®¸ÞºÎƾ(Trimebutine) vs. ½Ã¸ÞÆ®·ÎǾ(Cimetropium)?380 ¿°ÁõÀåÁúȯ?Inflammatory Bowel Disease, IBD?383 ¸Þ»ì¶óÁø(Mesalazine) vs. ¼³ÆÄ»ì¶óÁø(Sulfasalazine)?385 ÀÎÇø¯½Ã¸Ê(Infliximab) vs. º£µ¹¸®ÁÖ¸¿(Vedolizumab)?390 ±¸¿ª°ú ±¸Åä?Nausea and Vomiting?395 ¸Ö¹Ì?Motion Sickness?397 µ¼Æä¸®µ·(Domperidone) vs. ¸ÞÅäŬ·ÎÇÁ¶ó¹Ìµå(Metoclopramide)?398 ¿Â´Ü¼¼Æ®·Ð(Ondansetron) vs. ¾ÆÇÁ·¹ÇÇźƮ(Aprepitant)?402 ¾ÆÇÁ·¹ÇÇźƮ(Aprepitant) vs. ³×ÅõÇÇźƮ/ÆÈ·Î³ë¼¼Æ®·Ð(Netupitant/Palonosetron)?406 ½ºÄÚÆú¶ó¹Î ÆÐÃë(Scopolamine) vs. µð¸àÈ÷µå¸®³×ÀÌÆ® º¹ÇÕÁ¦Á¦(Dimenhydrinate)?411 µð¸àÈ÷µå¸®³×ÀÌÆ®(Dimenhydrinate) vs. º£Å¸È÷½ºÆ¾(Betahistine)?415 ·¹º¸¼³ÇǸ®µå(Levosulpiride) vs. ¸ð»çÇÁ¸®µå(Mosapride)?419 º£½ºÀÚÀÓ vs. º£³ªÄ¡¿À¿¡ÇÁ?423 6 °£ Áúȯ 433 ¹ÙÀÌ·¯½º¼º °£¿°?Viral Hepatitis?435 ¿£Å×Ä«ºñ¸£(Entecavir) vs. Å׳ëÆ÷ºñ¸£(Tenofovir DF)?438 ¿¤¹Ù½ººñ¸£/±×¶óÁ¶ÇÁ·¹ºñ¸£(Elbasvir/Grazoprevir) vs. ±Û·¹Ä«ÇÁ·¹ºñ¸£/ÇǺ귻Ÿ½ººñ¸£(Glecaprevir/Pibrentasvir)?441 °£¼º³úÁõ?Hepatic Encephalopathy?447 ¶ôÅø·Î¿À½º(Lactulose) vs. ¸®ÆÅ½Ã¹Î(Rifaximin)?449 7 ½ÅÀå Áúȯ 455 ¸¸¼ºÄáÆÏº´?Chronic Kidney Disease, CKD?457 ¼¼º§¶ó¸Óź»ê¿°(Sevelamer carbonate) vs. ź»ê¶õź(Lanthanum carbonate)?459 ¼öÅ©·ÎÁ¦ÀÌö(Sucroferric oxyhydroxide) vs. Ä®½ÃÆäµð¿Ã(Calcifediol hydrate)?464 »çÀÌŬ·Î½ºÆ÷¸°(Cyclosporine) vs. ½Ã·Ñ¸®¹«½º(Sirolimus)?469 Ÿũ·Î¸®¹«½º(Tacrolimus) vs. ¹ÌÄÚÆä³î·¹ÀÌÆ®(Mycophenolate)?474 8 ºñ´¢»ý½Ä±â Áúȯ 481 ¿ä½Ç±Ý?Urinary Incontinence?483 Àü¸³»ùºñ´ëÁõ?Benign Prostatic Hyperplasia, BPH?486 ÅçÅͷεò(Tolterodine) vs. ¼Ö¸®Æä³ª½Å(Solifenacin)?488 ¿Á½ÃºÎƼ´Ñ(Oxybutynin) vs. Æ®·Î½ºÇ¾(Trospium)?491 Æä¼ÒÅ׷εò(Fesoterodine) vs. ¹Ì¶óº£±×·Ð(Mirabegron)?496 ޽º·Î½Å(Tamsulosin) vs. Å×¶óÁ¶½Å(Terazosin)?500 ¾ËǪÁ¶½Å(Alfuzosin) vs. ½Ç·Îµµ½Å(Silodosin)?505 Çdzª½ºÅ׸®µå(Finasteride) vs. µÎŸ½ºÅ׸®µå(Dutasteride)?509 ¹ß±âºÎÀü?Erectile Dysfunction?515 ½Çµ¥³ªÇÊ(Sildenafil) vs. Ÿ´Ù¶óÇÊ(Tadalafil)?517 ¾ß´¢Áõ?Nocturnal Enuresis?521 µ¥½º¸ðÇÁ·¹½Å(Desmopressin) vs. À̹ÌÇÁ¶ó¹Î(Imipramine)?522 ã¾Æº¸±â?531
±¸¸ÅÈıâ
ÀÌ »óǰ¿¡ ´ëÇÑ ±¸¸ÅÈıâ´Â ±¸¸ÅÇϽŠºÐ¿¡ ÇÑÇØ 'ÁÖ¹®/¹è¼ÛÁ¶È¸'¿¡¼­ ÀÛ¼ºÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
¸¸Á·µµ¼ø
Ãֽżø
ÀÛ¼ºµÈ ±¸¸ÅÈıⰡ ¾ø½À´Ï´Ù.
    »óǰQ&A
    »óǰ¿¡ °üÇÑ ±Ã±ÝÇϽŠ»çÇ×À» ¹°¾îº¸¼¼¿ä!
    ±Û¾²±â
    ±Û¾²±â
      ¹è¼Û/±³È¯/ȯºÒ ¾È³»
      ¹è¼Û¾È³»
      - ÁÖ¹®±Ý¾×ÀÌ 15,000¿ø ÀÌ»óÀÎ °æ¿ì ¹«·á¹è¼Û, 15,000 ¹Ì¸¸ÀÎ °æ¿ì ¹è¼Ûºñ 2,500¿øÀÌ ºÎ°úµË´Ï´Ù. (´Ü, ¹«·á¹è¼Û »óǰÀÇ °æ¿ì Á¦¿Ü)
      - ÁÖ¹® ÈÄ ¹è¼ÛÁö¿ª¿¡ µû¶ó ±¹³» ÀϹÝÁö¿ªÀº ±Ù¹«ÀÏ(¿ù-±Ý) ±âÁØ 1Àϳ» Ãâ°íµÊÀ» ¿øÄ¢À¸·Î Çϳª, ±â»ó»óȲ µîÀÇ ÀÌÀ¯·Î Áö¿¬µÉ ¼öµµ ÀÖ½À´Ï´Ù. (´Ü, ÀÏ¿äÀÏ ¹× °øÈÞÀÏ¿¡´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.)
      - µµ¼­ »ê°£ Áö¿ª ¹× Á¦ÁÖµµÀÇ °æ¿ì´Â Ç×°ø/µµ¼± Ãß°¡¿îÀÓÀÌ ºÎ°úµÉ ¼ö ÀÖ½À´Ï´Ù.
      - ÇØ¿ÜÁö¿ªÀ¸·Î´Â ¹è¼ÛµÇÁö ¾Ê½À´Ï´Ù.
      ±³È¯/ȯºÒ ¾È³»
      - »óǰÀÇ Æ¯¼º¿¡ µû¸¥ ±¸Ã¼ÀûÀÎ ±³È¯ ¹× ȯºÒ±âÁØÀº °¢ »óǰÀÇ '»ó¼¼Á¤º¸'¸¦ È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
      - ±³È¯ ¹× ȯºÒ½ÅûÀº °¡°Ô ¿¬¶ôó·Î ÀüÈ­ ¶Ç´Â À̸ÞÀÏ·Î ¿¬¶ôÁֽøé ÃÖ¼±À» ´ÙÇØ ½Å¼ÓÈ÷ ó¸®ÇØ µå¸®°Ú½À´Ï´Ù.

      ±³È¯ ¹× ȯºÒ °¡´É »óǰ¿¡
      ¹®Á¦°¡ ÀÖÀ» °æ¿ì
      1) »óǰÀÌ Ç¥½Ã/±¤°íµÈ ³»¿ë°ú ´Ù¸£°Å³ª ºÒ·®(ºÎÆÐ, º¯Áú, ÆÄ¼Õ, Ç¥±â¿À·ù, À̹°È¥ÀÔ, Áß·®¹Ì´Þ)ÀÌ ¹ß»ýÇÑ °æ¿ì
      - ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ : ¼ö·ÉÀÏ ´ÙÀ½³¯±îÁö ½Åû
      - ±âŸ »óǰ : ¼ö·ÉÀϷκÎÅÍ 30ÀÏ À̳», ±× »ç½ÇÀ» ¾È ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳» ½Åû
      2) ±³È¯ ¹× ȯºÒ½Åû ½Ã ÆÇ¸ÅÀÚ´Â »óǰÀÇ »óŸ¦ È®ÀÎÇÒ ¼ö ÀÖ´Â »çÁøÀ» ¿äûÇÒ ¼ö ÀÖÀ¸¸ç »óǰÀÇ ¹®Á¦ Á¤µµ¿¡ µû¶ó Àç¹è¼Û, ÀϺÎȯºÒ, ÀüüȯºÒÀÌ ÁøÇàµË´Ï´Ù. ¹Ýǰ¿¡ µû¸¥ ºñ¿ëÀº ÆÇ¸ÅÀÚ ºÎ´ãÀ̸ç ȯºÒÀº ¹ÝǰµµÂøÀϷκÎÅÍ ¿µ¾÷ÀÏ ±âÁØ 3ÀÏ À̳»¿¡ ¿Ï·áµË´Ï´Ù.
      ´Ü¼øº¯½É ¹×
      ÁÖ¹®Âø¿ÀÀÇ °æ¿ì
      1) ½Å¼±½Äǰ, ³ÃÀå½Äǰ, ³Ãµ¿½Äǰ
      ÀçÆÇ¸Å°¡ ¾î·Á¿î »óǰÀÇ Æ¯¼º»ó, ±³È¯ ¹× ȯºÒÀÌ ¾î·Æ½À´Ï´Ù.
      2) È­Àåǰ
      ÇǺΠƮ·¯ºí ¹ß»ý ½Ã Àü¹®ÀÇ Áø´Ü¼­ ¹× ¼Ò°ß¼­¸¦ Á¦ÃâÇϽøé ȯºÒ °¡´ÉÇÕ´Ï´Ù. ÀÌ °æ¿ì Á¦¹Ýºñ¿ëÀº ¼ÒºñÀÚ ºÎ´ãÀ̸ç, ¹è¼Ûºñ´Â ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù. ÇØ´ç È­Àåǰ°ú ÇǺΠƮ·¯ºí°úÀÇ »ó´çÇÑ Àΰú°ü°è°¡ ÀÎÁ¤µÇ´Â °æ¿ì ¶Ç´Â Áúȯġ·á ¸ñÀûÀÇ °æ¿ì¿¡´Â Áø´Ü¼­ ¹ß±Þºñ¿ëÀ» ÆÇ¸ÅÀÚ°¡ ºÎ´ãÇÕ´Ï´Ù.
      3) ±âŸ »óǰ
      ¼ö·ÉÀϷκÎÅÍ 7ÀÏ À̳» ½Åû, ¿Õº¹¹è¼Ûºñ´Â ¼ÒºñÀÚ ºÎ´ã
      4) ¸ð´ÏÅÍ ÇØ»óµµÀÇ Â÷ÀÌ·Î »ö»óÀ̳ª À̹ÌÁö°¡ ´Ù¸¥ °æ¿ì ´Ü¼øº¯½É¿¡ ÀÇÇÑ ±³È¯ ¹× ȯºÒÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
      ±³È¯ ¹× ȯºÒ ºÒ°¡ 1) ½Åû±âÇÑÀÌ Áö³­ °æ¿ì
      2) ¼ÒºñÀÚÀÇ °ú½Ç·Î ÀÎÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ Àüü ¶Ç´Â ÀϺΰ¡ ¾ø¾îÁö°Å³ª ÈѼÕ, ¿À¿°µÇ¾úÀ» °æ¿ì
      3) °³ºÀÇÏ¿© ÀÌ¹Ì ¼·ÃëÇÏ¿´°Å³ª »ç¿ë(Âø¿ë ¹× ¼³Ä¡ Æ÷ÇÔ)ÇØ »óǰ ¹× ±¸¼ºÇ°ÀÇ °¡Ä¡°¡ ¼Õ»óµÈ °æ¿ì
      4) ½Ã°£ÀÌ °æ°úÇÏ¿© »óǰÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
      5) »ó¼¼Á¤º¸ ¶Ç´Â »ç¿ë¼³¸í¼­¿¡ ¾È³»µÈ ÁÖÀÇ»çÇ× ¹× º¸°ü¹æ¹ýÀ» ÁöŰÁö ¾ÊÀº °æ¿ì
      6) »çÀü¿¹¾à ¶Ç´Â ÁÖ¹®Á¦ÀÛÀ¸·Î ÅëÇØ ¼ÒºñÀÚÀÇ ÁÖ¹®¿¡ µû¶ó °³º°ÀûÀ¸·Î »ý»êµÇ´Â »óǰÀÌ ÀÌ¹Ì Á¦ÀÛÁøÇàµÈ °æ¿ì
      7) º¹Á¦°¡ °¡´ÉÇÑ »óǰ µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
      8) ¸À, Çâ, »ö µî ´Ü¼ø ±âÈ£Â÷ÀÌ¿¡ ÀÇÇÑ °æ¿ì